Pulmo BioTech Inc. Announces Paper to be Presented at... (early indications are that PulmoBind cou...)

Pulmo BioTech Inc. Announces Paper to be Presented at Symposium

Date:5/4/2009

early indications are that PulmoBind could be highly effective in the early stage diagnosis of Pulmonary Hypertension, a condition for which there is no current front line diagnostic test. The addressable market for the product candidates being developed by PulmoScience is believed by the company to be worth in excess of $500 million per annum.

Further Information

For further information regarding Pulmo BioTech Inc. or PulmoScience, please visit www.pulmobiotech.com.

Forward-Looking Statements

Forward-looking statements contained in this and other written and oral reports are made based on known events and circumstances at the time of release, and as such, are subject in the future to unforeseen uncertainties and risks. All statements regarding future performance, earnings projections, regulatory approval, events or developments are forward-looking statements. It is possible that the future performance of the company may differ materially from current expectations, depending on economic conditions and the uncertainty of regulatory approval. A change in economic conditions may have a particularly volatile effect on results. Among the other factors which may affect future performance are: competitive market conditions and resulting effects on sales and pricing; increases in raw-material costs that cannot be recovered in product pricing; and global economic factors, including difficulties entering new markets and general economic conditions such as inflation, interest rates and credit availability. The company makes these statements as of the date of this disclosure, and undertakes no obligation to update them.

ISIN: US7458451074

CUSIP: 745845107

SOURCE Pulmo BioTech Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
2. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
3. Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
4. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
5. Pulmonary Hypertension Association Names Recipient of 2008 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
6. Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
7. Pulmo BioTech Announces an Increase in its Stake in PulmoScience
8. Nektar Receives Patent Covering Pulmonary Targeted Antibiotics
9. Pulmo BioTech Announces Appointment of Chief Financial Officer
10. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
11. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve

Post Your Comments:

(Date:12/16/2009)... have developed a simple, cheap, accurate test to find ... have created a custom-made bacteria that glows green when ... explosives. , The bacteria can be mixed into a ... forms green patches to indicate the presence of landmines. ... cheap to produce, could be delivered from the air ...

(Date:12/16/2009)... Dec. 16 Martek Biosciences Corporation (Nasdaq: ... fourth quarter and fiscal year ended October 31, 2009. ... 3% from $90.4 million in the fourth quarter of ... per diluted share, for the fourth quarter of fiscal ... $0.31 per diluted share, in last year,s fourth quarter. ...

(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...

(Date:12/16/2009)... ultimate CHO cell culture supplement? InVitria has what scientists have ... media supplement that improves the growth and productivity of CHO ... Zap-CHO is an animal free, well defined and consistent recombinant ... ... CO (PRWEB) December 16, 2009 -- Scientists working with CHO ...

[0] Simple test could offer cheap solution to detecting landmines [0] Martek Announces Fourth Quarter and FY 2009 Financial Results [0] Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth [0] Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance

... GE Healthcare announced today that Rockwood ... facilities in the Spokane, Washington area, has purchased a ... of the new technologies the clinic is installing is ... appointments, update their patient profile and make co-payments electronically. ...

... (Commerce) has qualified five small businesses for investor tax ... Tax Credit Programs. , ,"By encouraging investors through tax ... to turn these great ideas into viable, job-creating businesses," ... and Venture Fund Tax Credit Programs offer Wisconsin income ...

... National Committee for Quality Assurance (NCQA) has ... as the first electronic health record (EHR) software shown ... American Diabetes Association Diabetes Physician Recognition Program (DPRP). ... required to pull a random sample of their patient ...

Other Biology Technology:Five technology companies qualify for investor tax credits 2

GE Healthcare Software installed at clinic in Washington Five technology companies qualify for investor tax credits GE health record system certified

(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...

(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...

(Date:12/15/2009)... available in German ., Despite the ... the globe, cultures vary as to how space is ... use egocentric terms such as ,left, right, front, back, ... like ,north, south, east, west, at all times for ... or "There is an snake by your Northern leg". ...

[0] UF to lead national effort to help patients with rare brain disease [0] GenWay Clinical Laboratory receives accreditation from College of American Pathologists [1] More than a jump to the left

... growing faster than anywhere else in the world. This is ... urban environment and effect of cities on rural areas. One ... being over-looked. , Joy Clancy from the University of Twente ... African Journal of Ecology . She says "A hundred ...

... climate change, pollution and human activity. ESA,s ERS and ... region for the last 17 years. These long term ... be key in implementing the newly adopted European Commission ... , The policy highlights new opportunities in the region ...

... fish are prompting widespread consumption advisories and uncertainty among ... researchers at North Carolina State University have developed a ... country predict which areas are likely to have fish ... help officials address public uncertainty by developing health advisories ...

Other Biology News:ESA satellites focusing on the Arctic 2 New model predicts hot spots for mercury in fish 2

Ecological impact of African cities ESA satellites focusing on the Arctic New model predicts hot spots for mercury in fish

...

... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related ... continual availability of new radiolabeled ligands selected ... offers a wide range of products and ... including over 400 state-of-the-art radioligands. If you ...

... was developed using a protein engineering approach that ... pocket of wild-type DNase I. These changes markedly ... The result is a versatile enzyme that has ... ability to maintain at least 50% of peak ...

Biology Products:

[14C(U)]-L-Amino Acid Mixture, 250Ci (9.25MBq) from PerkinElmer Product Information Request - U-0080D Diode Array Bio-Spectrophotometer from Hitachi High Technologies America Porcine Neuromedin U-25 , 125I Conjugated/Tagged from PerkinElmer TURBO DNase (2 U/l) from Ambion

Pulmo BioTech Inc. Announces Paper to be Presented at...(early indications are that PulmoBind cou...)